Volume 10, Number 1 (Jan/Feb 2019)

The Debate Over Alcohol Consumption: How Much Is Too Much?

Fitness and Quality of Life Outcomes of Cancer Survivor Participants in a Community Exercise Program

Abstract Exercise is recommended for cancer survivors, as it mitigates treatment side effects and improves overall wellness. Therefore, survivors attend community-based exercise programs and report positive results, but published evalua...

Botulinum Toxin for Side-Effect Management and Prevention of Surgical Complications in Patients Treated for Head and Neck Cancers and Esophageal Cancer

Abstract The management of head and neck cancers (HNC) and esophageal cancer (EC) is complex and often involves multiple modalities of treatment, including chemotherapy, radiation therapy, and surgery. The side effects associated with t...

Breast Implant–Associated Anaplastic Large Cell Lymphoma: What We Know

Abstract Breast implant–associated anaplastic large cell lymphoma (BIA-ALCL) is a rare peripheral T-cell lymphoma, first reported in 1997. It is pathologically confirmed as a CD30-positive, anaplastic lymphoma kinase (ALK)–negative ALCL...

Methylnaltrexone: Peripherally Acting μ-Opioid Receptor Antagonist

Abstract Opioid-induced constipation (OIC) is a common adverse effect associated with opioid therapy, with many patients never developing tolerance to this effect. There are many traditional laxatives available to help patients combat t...

Gemtuzumab Ozogamicin: Back Again

Abstract Despite the recent onslaught of approved medications in oncology, acute myeloid leukemia (AML) has been a disease state bereft of pharmaceutical development for decades. The long-standing first-line regimen, 7 + 3, was develope...

Evidence-Based Oncology Practice: Competencies for Improved Patient Outcomes

Abstract Oncology advanced practice providers (APP) play a critical role in providing cancer care to patients and families. Given the rate of scientific advancement, APPs are challenged to keep with the pace of science and acquire tools...